We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Integrated Diagnostics Holdings Plc | IDHC | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.42 | 0.42 | 0.422 | 0.4205 | 0.4125 |
Top Posts |
---|
Posted at 06/12/2022 13:09 by brucie5 Hmm. Large buy reported here: wonder if it's the boss' investment proxy hoovering up off the floor again. She owns c. 26% of the company, I believe.06-Dec-22 12:45:55 0.686 300,000 Buy* 0.672 0.70 205.80k This link is quite interesting in showing who the buyers/sellers have been over last months. |
Posted at 06/12/2022 08:39 by brucie5 I may have made a mistake by holding, nevermind adding here. But I do notice that the dividend was paid in full to small investors over the summer, at at 8.6% current, it's still an income stock. But also the ROE, ROC and operating margin are all top in their sector. So a nifty business, with severe currency headwinds. |
Posted at 23/12/2019 11:47 by trytotakeiteasy Not sure that can be the reason because surely the only exchange rate that matters is Egyptian pound to sterling. Sure they report in US dollars but that is by the by. They earn money in Egyptian pounds and their investors are mainly in the UK. |
Posted at 06/9/2016 16:52 by rambutan2 May 2015The initial public offering (IPO) of Egypt’s largest medical diagnostics company on the London Stock Exchange was 11.2 times oversubscribed suggesting heavy foreign appetite for an Egyptian firm operating across the Middle East. EFG Hermes was the joint global coordinator and joint book-runner on the IPO which offered 43.5% of IDH shares in the first ever IPO for a medical firm operating in Egypt in London Stock Exchange since 2008. Commenting on the listing Dr. Hend El Sherbini, Chief Executive Officer at IDH, said: “Today represents a key milestone in the IDH growth story. Our initial public offering will allow us to further accelerate our market penetration. Increase our profile and brand recognition, expand our service offerings in our target markets. We warmly welcome our new investors to share in the next, exciting stage of our growth and development.” |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions